AI
Digital Infrastructure
Future Mobility & Energy
Life Science & Health
Industry 5.0
Startup
-
Date
10:20-10:25
Chairman’s Opening
10:30-10:50
Generative AI in Drug Discovery: Can It Really Shorten the Preclinical Path?
Speaker:Chris LAI, Chairman & CEO, METiS Pharmaceuticals
10:55-11:15
AI+ Quantum Computing: the Swiss Army Knife for Hunting Down the Next Billion-dollar GLP Target
Speaker: Xiaoran LI, CEO & Co-Funder, QureGenAI
11:20-12:00
Panel Discussion: China’s Biotech Ambition vs. Localization Realities — Breaking Down the Walls to a Global Future
12:10-13:25
Visit Expo & Networking
13:45-13:50
Chairman’s Opening
13:55-14:15
Senolytics and Longevity Medicine: From Lab to Clinic
14:20-14:40
AI Drug Discovery: Real-World Data from Screening toPhase II
14:45-15:05
AI-Powered LNP: Breakthroughs in Anti-AgingTherapeutics
Speaker:Zhu Yuchao, General Manager, HanxinBiotechnology
15:10-15:30
Digital Twin Organs: Can Virtual Trials Replace HumanVolunteers?
Speaker:Speaker: Qiancheng SHEN, Co-Founder, Chairman & CEO, NUTSHELL Therapeutics Inc
15:35-16:20
Panel Discussion: AI-Generated Control Arms — Cost-Saver for RCTs or Minefield for NDAs?
16:25-16:30
Chair’s Closing Remarks
09:50-09:55
Chairman’s Opening
09:55-10:15
Remote Surgery via 5G: Private Networks and Regulatory Innovation
10:20-10:40
Wearables’ Next Frontier: From Consumer Heart Rate to Medical-Grade Glucose and Blood Pressure
Speaker: Qiran JU, Senior Analyst, Consumer, Tech Target
10:45-11:05
From Concept to Care: Can Checkups Go from One- Size-Fits-All to Truly Personalized?
Speaker: Gao Jianxiong, Vice President of Smart Health Cloud IaaS Open Platform Division, iKang Group
11:10-12:00
Panel: From Data to Therapy — What’s Slowing Down AI in the Clinic?
12:00-13:25
Visit Expo and Networking
13:25-13:30
Chairman’s Opening
13:30-13:50
Surgical Robots: From Automation to Intraoperative AI
13:55-14:15
In Vivo Gene Editing: From Lab Bench to Bedside
14:20-14:40
Brain-Computer Interface (BCI) for Neurorehabilitation: From Lab to Clinic
14:45-15:05
Closed-Loop Adaptive Therapy: From One-Drug-OneDisease to Real-Time Regulation
15:10-16:00
Panel Discussion: Automation’s Black Box — From Cell Prep to Surgery, Where’s the Line of Trust?
16:00-16:05
Chair’s Closing Remarks
10:10-10:15
Chairman’s Opening
10:20-10:40
Risk and Regulatory Sandboxes for Medical AI Models
10:45-11:05
Phased Approvals for AI Devices: FDA TAP, NMPA Green Channels, and EU MDR Compared
11:10-12:00
Panel Discussion: From Treatment to Prevention — Business Models and the New Payer Reality
12:00-13:25
Visit Expo and Networking
13:45-13:50
Chairman’s Opening
13:55-14:15
Digital Therapeutics: From Transaction to Lifetime Care — The Reimbursement Puzzle
14:20-15:05
Panel Discussion: The Precision Medicine Ecosystem — Can Research, Industry, Payers, and Regulators Align?
15:05-15:10
Chair’s Closing Remarks